Five myeloma experts share their top takeaways from IMS 2026, including the CERVINO trial and long-term follow-up from the PERSEUS study.
|Videos|March 15, 2018
Questions on Genetic Counseling in the Community Setting
Author(s)Catherine Fine, MS
Catherine Fine, MS, Certified Genetic Counselor, lead, Clinical Cancer Services at Genome Medical, discusses questions on genetic counseling in the community setting.
Advertisement
Catherine Fine, MS, Certified Genetic Counselor, lead, Clinical Cancer Services at Genome Medical, discusses questions on genetic counseling in the community setting.
A big question that community practices ask is about accreditation. As a telemedicine practice, Genome Medical can assist community cancer centers become accredited and maintain that accreditation, Fine says.
Newsletter
Stay up to date on practice-changing data in community practice.
SubscribeAdvertisement
Related to this article
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Adjuvant Atezolizumab Plus Chemo for dMMR Colon Cancer
2
Adding Quality of Life to Treatment Goals in Immune Thrombocytopenia
3
c-Met ADC Temab-A Gains 2 FDA Breakthrough Designations in CRC, NSCLC
4
FDA Approves Tucatinib Maintenance Regimen in HER2+ Metastatic Breast Cancer
5